102 related articles for article (PubMed ID: 30657574)
1. Correlations between the level of antibody against peptide of glutamate receptor NR3B subunit in the CSF and cognitive comorbidities of patients with epilepsy.
Li XY; Hu P; Li QY; Zhang M; Lai QW; Wang X; Fan HB; Yao RQ
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):328-337. PubMed ID: 30657574
[TBL] [Abstract][Full Text] [Related]
2. Autoimmune epilepsy: some epilepsy patients harbor autoantibodies to glutamate receptors and dsDNA on both sides of the blood-brain barrier, which may kill neurons and decrease in brain fluids after hemispherotomy.
Ganor Y; Goldberg-Stern H; Amrom D; Lerman-Sagie T; Teichberg VI; Pelled D; Futerman AH; Zeev BB; Freilinger M; Verheulpen D; Van Bogaert P; Levite M
Clin Dev Immunol; 2004; 11(3-4):241-52. PubMed ID: 15559370
[TBL] [Abstract][Full Text] [Related]
3. Glutamate receptor antibodies directed against AMPA receptors subunit 3 peptide B (GluR3B) associate with some cognitive/psychiatric/behavioral abnormalities in epilepsy patients.
Goldberg-Stern H; Ganor Y; Cohen R; Pollak L; Teichberg V; Levite M
Psychoneuroendocrinology; 2014 Feb; 40():221-31. PubMed ID: 24485494
[TBL] [Abstract][Full Text] [Related]
4. Antibodies to glutamate receptor subtype 3 (GluR3) are found in some patients suffering from epilepsy as the main disease, but not in patients whose epilepsy accompanies antiphospholipid syndrome or Sneddon's syndrome.
Ganor Y; Goldberg-Stern H; Blank M; Shoenfeld Y; Dobrynina LA; Kalashnikova L; Levite M
Autoimmunity; 2005 Sep; 38(6):417-24. PubMed ID: 16278146
[TBL] [Abstract][Full Text] [Related]
5. Glutamate receptor antibodies directed against AMPA receptors subunit 3 peptide B (GluR3B) can be produced in DBA/2J mice, lower seizure threshold and induce abnormal behavior.
Ganor Y; Goldberg-Stern H; Cohen R; Teichberg V; Levite M
Psychoneuroendocrinology; 2014 Apr; 42():106-17. PubMed ID: 24636507
[TBL] [Abstract][Full Text] [Related]
6. Monozygotic twins discordant for epilepsy differ in the levels of potentially pathogenic autoantibodies and cytokines.
Ganor Y; Freilinger M; Dulac O; Levite M
Autoimmunity; 2005 Mar; 38(2):139-50. PubMed ID: 16040334
[TBL] [Abstract][Full Text] [Related]
7. GluR3B Ab's induced oligodendrocyte precursor cells excitotoxicity via mitochondrial dysfunction.
Liu Y; Chen Y; Du WT; Wu XX; Dong FX; Qu XB; Fan HB; Yao RQ
Brain Res Bull; 2017 Apr; 130():60-66. PubMed ID: 28063880
[TBL] [Abstract][Full Text] [Related]
8. Semi-quantitative analyses of antibodies to N-methyl-d-aspartate type glutamate receptor subunits (GluN2B & GluN1) in the clinical course of Rasmussen syndrome.
Fukuyama T; Takahashi Y; Kubota Y; Mogami Y; Imai K; Kondo Y; Sakuma H; Tominaga K; Oguni H; Nishimura S
Epilepsy Res; 2015 Jul; 113():34-43. PubMed ID: 25986190
[TBL] [Abstract][Full Text] [Related]
9. Antibodies against peptides of NMDA-type GluR in cerebrospinal fluid of patients with epileptic spasms.
Mori T; Takahashi Y; Araya N; Oboshi T; Watanabe H; Tsukamoto K; Yamaguchi T; Yoshitomi S; Nasu H; Ikeda H; Otani H; Imai K; Shigematsu H; Inoue Y
Eur J Paediatr Neurol; 2016 Nov; 20(6):865-873. PubMed ID: 27515477
[TBL] [Abstract][Full Text] [Related]
10. Immunization with the glutamate receptor-derived peptide GluR3B induces neuronal death and reactive gliosis, but confers partial protection from pentylenetetrazole-induced seizures.
Ganor Y; Gottlieb M; Eilam R; Otmy H; Teichberg VI; Levite M
Exp Neurol; 2005 Sep; 195(1):92-102. PubMed ID: 15907325
[TBL] [Abstract][Full Text] [Related]
11. Circulating regulatory anti-T cell receptor antibodies in patients with myasthenia gravis.
Jambou F; Zhang W; Menestrier M; Klingel-Schmitt I; Michel O; Caillat-Zucman S; Aissaoui A; Landemarre L; Berrih-Aknin S; Cohen-Kaminsky S
J Clin Invest; 2003 Jul; 112(2):265-74. PubMed ID: 12865414
[TBL] [Abstract][Full Text] [Related]
12. Is the Bahasa Malaysia version of the Montreal Cognitive Assessment (MoCA-BM) a better instrument than the Malay version of the Mini Mental State Examination (M-MMSE) in screening for mild cognitive impairment (MCI) in the elderly?
Razali R; Jean-Li L; Jaffar A; Ahmad M; Shah SA; Ibrahim N; Din NC; Nik Jaafar NR; Midin M; Sidi H; Ahmad S
Compr Psychiatry; 2014 Jan; 55 Suppl 1():S70-5. PubMed ID: 24314103
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the Mini-Mental State Examination and Montreal Cognitive Assessment executive subtests in detecting post-stroke cognitive impairment.
Fu C; Jin X; Chen B; Xue F; Niu H; Guo R; Chen Z; Zheng H; Wang L; Zhang Y
Geriatr Gerontol Int; 2017 Dec; 17(12):2329-2335. PubMed ID: 28675607
[TBL] [Abstract][Full Text] [Related]
14. Neuronal antibodies in pediatric epilepsy: Clinical features and long-term outcomes of a historical cohort not treated with immunotherapy.
Wright S; Geerts AT; Jol-van der Zijde CM; Jacobson L; Lang B; Waters P; van Tol MJ; Stroink H; Neuteboom RF; Brouwer OF; Vincent A
Epilepsia; 2016 May; 57(5):823-31. PubMed ID: 26996997
[TBL] [Abstract][Full Text] [Related]
15. Febrile infection-related epilepsy syndrome without detectable autoantibodies and response to immunotherapy: a case series and discussion of epileptogenesis in FIRES.
van Baalen A; Häusler M; Plecko-Startinig B; Strautmanis J; Vlaho S; Gebhardt B; Rohr A; Abicht A; Kluger G; Stephani U; Probst C; Vincent A; Bien CG
Neuropediatrics; 2012 Aug; 43(4):209-16. PubMed ID: 22911482
[TBL] [Abstract][Full Text] [Related]
16. Montreal Cognitive Assessment in cryptogenic epilepsy patients with normal Mini-Mental State Examination scores.
Phabphal K; Kanjanasatien J
Epileptic Disord; 2011 Dec; 13(4):375-81. PubMed ID: 22258041
[TBL] [Abstract][Full Text] [Related]
17. Removal of anti-Galalpha1,3Gal xenoantibodies with an injectable polymer.
Katopodis AG; Warner RG; Duthaler RO; Streiff MB; Bruelisauer A; Kretz O; Dorobek B; Persohn E; Andres H; Schweitzer A; Thoma G; Kinzy W; Quesniaux VF; Cozzi E; Davies HF; Mañez R; White D
J Clin Invest; 2002 Dec; 110(12):1869-77. PubMed ID: 12488437
[TBL] [Abstract][Full Text] [Related]
18. Dysfunction of the blood-cerebrospinal fluid-barrier and N-methyl-D-aspartate glutamate receptor antibodies in dementias.
Busse M; Kunschmann R; Dobrowolny H; Hoffmann J; Bogerts B; Steiner J; Frodl T; Busse S
Eur Arch Psychiatry Clin Neurosci; 2018 Aug; 268(5):483-492. PubMed ID: 28176002
[TBL] [Abstract][Full Text] [Related]
19. Montreal cognitive assessment reflects cognitive reserve.
Kang JM; Cho YS; Park S; Lee BH; Sohn BK; Choi CH; Choi JS; Jeong HY; Cho SJ; Lee JH; Lee JY
BMC Geriatr; 2018 Oct; 18(1):261. PubMed ID: 30376815
[TBL] [Abstract][Full Text] [Related]
20. The validation of the Beijing version of the Montreal Cognitive Assessment in Chinese patients undergoing hemodialysis.
Tian R; Guo Y; Ye P; Zhang C; Luo Y
PLoS One; 2020; 15(1):e0227073. PubMed ID: 31917792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
